Oppenheimer Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.6M | Sell |
17,725
-469
| -3% | -$264K | 0.1% | 226 |
|
|
2026
Q1 | $10.8M | Sell |
18,194
-189
| -1% | -$94.1K | 0.12% | 191 |
|
|
2025
Q4 | $8.96M | Sell |
18,383
-127
| -0.7% | -$59.1K | 0.11% | 212 |
|
|
2025
Q3 | $7.76M | Buy |
18,510
+1,806
| +11% | +$607K | 0.09% | 258 |
|
|
2025
Q2 | $4.8M | Sell |
16,704
-412
| -2% | -$123K | 0.06% | 354 |
|
|
2025
Q1 | $5.28M | Sell |
17,116
-1,124
| -6% | -$385K | 0.07% | 307 |
|
|
2024
Q4 | $6.44M | Sell |
18,240
-6,988
| -28% | -$2.57M | 0.08% | 274 |
|
|
2024
Q3 | $9.04M | Sell |
25,228
-624
| -2% | -$211K | 0.11% | 212 |
|
|
2024
Q2 | $8.24M | Buy |
25,852
+547
| +2% | +$145K | 0.11% | 220 |
|
|
2024
Q1 | $5.81M | Sell |
25,305
-2,228
| -8% | -$503K | 0.09% | 260 |
|
|
2023
Q4 | $6.05M | Sell |
27,533
-3,544
| -11% | -$817K | 0.08% | 267 |
|
|
2023
Q3 | $7.02M | Sell |
31,077
-1,300
| -4% | -$299K | 0.11% | 223 |
|
|
2023
Q2 | $7.15M | Sell |
32,377
-1,060
| -3% | -$235K | 0.11% | 224 |
|
|
2023
Q1 | $7.49M | Sell |
33,437
-540
| -2% | -$133K | 0.12% | 203 |
|
|
2022
Q4 | $9.45M | Sell |
33,977
-393
| -1% | -$99.2K | 0.15% | 173 |
|
|
2022
Q3 | $7.2M | Sell |
34,370
-527
| -2% | -$118K | 0.13% | 208 |
|
|
2022
Q2 | $8.22M | Sell |
34,897
-651
| -2% | -$132K | 0.14% | 175 |
|
|
2022
Q1 | $6.38M | Buy |
35,548
+2,462
| +7% | +$469K | 0.09% | 247 |
|
|
2021
Q4 | $7.15M | Sell |
33,086
-732
| -2% | -$144K | 0.09% | 242 |
|
|
2021
Q3 | $6.24M | Sell |
33,818
-777
| -2% | -$153K | 0.09% | 266 |
|
|
2021
Q2 | $6.21M | Buy |
+34,595
| New | +$6.59M | 0.09% | 264 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | -$1K | – | 1429 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 1490 |
|
|
2019
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1590 |
|
|
2019
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 1645 |
|
|
2019
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1660 |
|
|
2019
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 1589 |
|
|
2018
Q4 | $1K | Buy |
+6
| New | +$696 | ﹤0.01% | 1616 |
|
|
2017
Q4 | – | Sell |
-6
| Closed | -$1K | – | 1476 |
|
|
2017
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1658 |
|
|
2017
Q2 | $1K | Sell |
6
-26
| -81% | -$3.24K | ﹤0.01% | 1648 |
|
|
2017
Q1 | $4K | Buy |
+32
| New | +$4.85K | ﹤0.01% | 1608 |
|
Other funds holding UTHR
ACA
JT
Oppenheimer Asset Management's UTHR Position: Q2 2026 in Review
Oppenheimer Asset Management reduced its United Therapeutics (UTHR) stake by 2.6% in Q2 2026, selling an estimated $264K and leaving 17,725 shares worth $9.6M. The position accounts for 0.1% of the portfolio, ranked #226.
Oppenheimer Asset Management first reported a position in UTHR in Q1 2017 and has held it in 30 quarters since. The position peaked at $10.8M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Oppenheimer Asset Management held 17,725 shares of United Therapeutics worth $9.6M as of Q2 2026.
- Oppenheimer Asset Management sold 469 United Therapeutics shares in Q2 2026, an estimated $264K.
- United Therapeutics made up 0.1% of Oppenheimer Asset Management's portfolio in Q2 2026, its #226 holding.
- Oppenheimer Asset Management first reported a position in United Therapeutics in Q1 2017 and has held it in 30 quarters since.
- Oppenheimer Asset Management's United Therapeutics position peaked at $10.8M in Q1 2026.
- 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.